114 related articles for article (PubMed ID: 20846483)
21. Effect of statin on arginine metabolites in treated HIV-infection.
Dirajlal-Fargo S; El Kamari V; Sattar A; Alam K; Funderburg N; Labbato D; Pirro L; Longenecker CT; Wilson WH; McComsey GA
Atherosclerosis; 2017 Nov; 266():74-80. PubMed ID: 28992467
[TBL] [Abstract][Full Text] [Related]
22. Association of Circulating Levels of ADMA with Carotid Intima-Media Thickness in Patients with CKD: a Systematic Review and Meta-Analysis.
Wang F; Xiong R; Feng S; Lu X; Li H; Wang S
Kidney Blood Press Res; 2018; 43(1):25-33. PubMed ID: 29393214
[TBL] [Abstract][Full Text] [Related]
23. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
[TBL] [Abstract][Full Text] [Related]
24. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
25. Novel markers of endothelial dysfunction and inflammation in Behçet's disease patients with ocular involvement: epicardial fat thickness, carotid intima media thickness, serum ADMA level, and neutrophil-to-lymphocyte ratio.
Yuksel M; Yildiz A; Oylumlu M; Turkcu FM; Bilik MZ; Ekinci A; Elbey B; Tekbas E; Alan S
Clin Rheumatol; 2016 Mar; 35(3):701-8. PubMed ID: 25744156
[TBL] [Abstract][Full Text] [Related]
26. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia.
Lu TM; Ding YA; Leu HB; Yin WH; Sheu WH; Chu KM
Am J Cardiol; 2004 Jul; 94(2):157-61. PubMed ID: 15246890
[TBL] [Abstract][Full Text] [Related]
27. Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index.
Aso Y; Okumura K; Wakabayashi S; Takebayashi K; Taki S; Inukai T
J Clin Endocrinol Metab; 2004 Nov; 89(11):5713-7. PubMed ID: 15531533
[TBL] [Abstract][Full Text] [Related]
28. Asymmetric dimethylarginine and symmetric dimethylarginine prospectively relates to carotid wall thickening in black men: the SABPA study.
Mels CMC; Schutte AE; Huisman HW; Smith W; Kruger R; van Rooyen JM; Schwedhelm E; Atzler D; Böger RH; Malan NT; Malan L
Amino Acids; 2017 Nov; 49(11):1843-1853. PubMed ID: 28831582
[TBL] [Abstract][Full Text] [Related]
29. Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
Shoji T; Hatsuda S; Tsuchikura S; Shinohara K; Kimoto E; Koyama H; Emoto M; Nishizawa Y
Atherosclerosis; 2009 Feb; 202(2):582-8. PubMed ID: 18492490
[TBL] [Abstract][Full Text] [Related]
30. Carotid intima-media thickness and plasma asymmetric dimethylarginine in Mexican children exposed to inorganic arsenic.
Osorio-Yáñez C; Ayllon-Vergara JC; Aguilar-Madrid G; Arreola-Mendoza L; Hernández-Castellanos E; Barrera-Hernández A; De Vizcaya-Ruiz A; Del Razo LM
Environ Health Perspect; 2013 Sep; 121(9):1090-6. PubMed ID: 23757599
[TBL] [Abstract][Full Text] [Related]
31. Circulating plasma antioxidants, inflammatory markers and asymptomatic carotid atherosclerosis in end-stage renal disease patients: a case control study.
Riccioni G; D Orazio N; Scotti L; Petruzzelli R; Latino A; Bucciarelli V; Pennelli A; Cicolini G; Di Ilio E; Bucciarelli T
Int J Immunopathol Pharmacol; 2010; 23(1):327-34. PubMed ID: 20378019
[TBL] [Abstract][Full Text] [Related]
32. Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease.
Alsagaff MY; Thaha M; Aminuddin M; Yogiarto RM; Yogiantoro M; Tomino Y
J Int Med Res; 2012; 40(1):340-9. PubMed ID: 22429374
[TBL] [Abstract][Full Text] [Related]
33. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.
Eid HM; Eritsland J; Larsen J; Arnesen H; Seljeflot I
Atherosclerosis; 2003 Feb; 166(2):279-84. PubMed ID: 12535740
[TBL] [Abstract][Full Text] [Related]
34. Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis.
Zsuga J; Torok J; Magyar MT; Valikovics A; Gesztelyi R; Kéki S; Csiba L; Zsuga M; Bereczki D
Cerebrovasc Dis; 2007; 23(5-6):388-94. PubMed ID: 17406107
[TBL] [Abstract][Full Text] [Related]
35. Plasma antioxidants and asymptomatic carotid atherosclerotic disease.
Riccioni G; Bucciarelli T; D'Orazio N; Palumbo N; di Ilio E; Corradi F; Pennelli A; Bazzano LA
Ann Nutr Metab; 2008; 53(2):86-90. PubMed ID: 18936536
[TBL] [Abstract][Full Text] [Related]
36. Effects of atorvastatin in combination with ezetimibe on carotid atherosclerosis in elderly patients with hypercholesterolemia.
Luo P; Li L; Wang LX; Zhu HH; Du S; Wu SL; Han YG; Wang GG
Genet Mol Res; 2014 Apr; 13(2):2377-84. PubMed ID: 24737506
[TBL] [Abstract][Full Text] [Related]
37. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
Riccioni G; Vitulano N; Mancini B; Zanasi A; D'Orazio N
Pharmacology; 2010; 85(2):63-7. PubMed ID: 20110750
[TBL] [Abstract][Full Text] [Related]
38. Lycopene and preclinical carotid atherosclerosis.
Riccioni G; Scotti L; Di Ilio E; Bucciarelli V; Ballone E; De Girolamo M; D' Orazio N; Martini F; Aceto A; Bucciarelli T
J Biol Regul Homeost Agents; 2011; 25(3):435-41. PubMed ID: 22023768
[TBL] [Abstract][Full Text] [Related]
39. Umbilical cord asymmetric dimethylarginine levels and ultrasound assessment of carotid arteries in neonates born small for gestational age.
Dilli D; Ozkan E; Ozkan MB; Aydin B; Özyazici A; Fettah N; Zenciroğlu A; Okumuş N
J Matern Fetal Neonatal Med; 2017 Feb; 30(4):492-496. PubMed ID: 27072784
[TBL] [Abstract][Full Text] [Related]
40. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
